Elhassan Yasir Hassan, Alahmadi Fahad, Albadawi Emad Ali, Albarakati Abdullah, Aljohany Azizah Hendi, Alzaman Naweed SyedKhaleel, Albadrani Muayad
Department of Basic Medical Sciences, College of Medicine, Taibah University, Madinah 42353, Saudi Arabia.
Department of Women and Child Health, College of Medicine, Taibah University, Madinah 42353, Saudi Arabia.
Metabolites. 2024 Dec 16;14(12):709. doi: 10.3390/metabo14120709.
Congenital heart diseases are among the most common birth defects, significantly impacting infant health. Recent evidence suggests that exposure to endocrine-disrupting chemicals may contribute to the incidence of congenital heart diseases. This study systematically reviews and analyzes the association between maternal endocrine-disrupting chemicals exposure and congenital heart diseases.
This systematic review and meta-analysis followed the Cochrane Handbook and PRISMA guidelines. We included studies assessing the link between maternal exposure to various endocrine-disrupting chemicals and the incidence of congenital heart diseases without restricting the study design or exposure assessment methods. Data were extracted from four databases, including PubMed, Scopus, Web of Science, and Cochrane Library, up to June 2024. Quality assessment of observational studies was conducted using the Newcastle-Ottawa Scale. Statistical analysis was performed using RevMan software version 5.3, presenting results as odds ratios with 95% confidence intervals.
Fifty-nine studies were included in the meta-analysis. The pooled analysis revealed a significant association between maternal endocrine-disrupting chemical exposure and the incidence of congenital heart diseases when measured using human samples (odds ratio = 1.63, 95% confidence interval [1.35-1.97], < 0.00001). Notably, exposure to heavy metals, polycyclic aromatic hydrocarbons, and perfluoroalkyl compounds was strongly associated with congenital heart diseases. However, non-sample-based methods showed no significant overall correlation (odds ratio = 1.08, 95% confidence interval [0.93-1.26], = 0.30), except for housing renovation compounds, which were linked to a higher incidence of congenital heart diseases.
Maternal exposure to specific endocrine-disrupting chemicals, particularly heavy metals and polycyclic aromatic hydrocarbons, significantly increases the risk of congenital heart diseases. These findings underscore the need for preventive measures to reduce endocrine-disrupting chemicals exposure during pregnancy and further research to elucidate the underlying mechanisms.
先天性心脏病是最常见的出生缺陷之一,对婴儿健康有重大影响。最近的证据表明,接触内分泌干扰化学物质可能导致先天性心脏病的发病率上升。本研究系统评价并分析了母亲接触内分泌干扰化学物质与先天性心脏病之间的关联。
本系统评价和荟萃分析遵循Cochrane手册和PRISMA指南。我们纳入了评估母亲接触各种内分泌干扰化学物质与先天性心脏病发病率之间联系的研究,不限制研究设计或接触评估方法。截至2024年6月,数据从四个数据库中提取,包括PubMed、Scopus、科学网和Cochrane图书馆。使用纽卡斯尔-渥太华量表对观察性研究进行质量评估。使用RevMan 5.3软件进行统计分析,结果以比值比和95%置信区间表示。
荟萃分析纳入了59项研究。汇总分析显示,当使用人体样本测量时,母亲接触内分泌干扰化学物质与先天性心脏病的发病率之间存在显著关联(比值比 = 1.63,95%置信区间[1.35 - 1.97],P < 0.00001)。值得注意的是,接触重金属、多环芳烃和全氟烷基化合物与先天性心脏病密切相关。然而,基于非样本的方法总体上没有显示出显著相关性(比值比 = 1.08,95%置信区间[0.93 - 1.26],P = 0.30),但房屋装修化合物除外,其与先天性心脏病的较高发病率有关。
母亲接触特定的内分泌干扰化学物质,特别是重金属和多环芳烃,会显著增加先天性心脏病的风险。这些发现强调了采取预防措施以减少孕期内分泌干扰化学物质接触的必要性,以及进一步研究以阐明潜在机制的必要性。